We also analyzed the effect of Ambrisentan on the functional capacity of MDA‐MB231 breast adenocarcinoma, a cell line shown to be positive for ETAR expression (Fig. 2a). The gene discussed is EDNRA; the disease is breast adenocarcinoma.